{"rows":[{"id":6072,"title":"Single-dose psilocybin superior to placebo for MDD in community setting","authors":"","journal":"The Brown University Psychopharmacology Update","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1002/pu.31520","pubmed_id":null,"openalex_id":"https://openalex.org/W7233370665","source_url":"https://doi.org/10.1002/pu.31520","substance_tags":"psilocybin","topic_tags":"Depression,Treatment-Resistant Depression","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-11-15 02:20:13","last_checked":"2026-11-16 02:20:19","bibtex":null,"source_record_id":"DOI:10.1002/pu.31520","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/pu.31520","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1002/pu.31520","source_url":"https://doi.org/10.1002/pu.31520","doi":"10.1002/pu.31520","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-15 02:20:13","last_checked_at":"2026-11-16 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6072#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6071,"title":"Pilot study supports broader research on psilocybin for anorexia nervosa","authors":"","journal":"The Brown University Psychopharmacology Update","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1002/pu.31522","pubmed_id":null,"openalex_id":"https://openalex.org/W7231913679","source_url":"https://doi.org/10.1002/pu.31522","substance_tags":"psilocybin","topic_tags":"Eating Disorders","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-11-15 02:20:13","last_checked":"2026-11-16 02:20:19","bibtex":null,"source_record_id":"DOI:10.1002/pu.31522","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/pu.31522","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1002/pu.31522","source_url":"https://doi.org/10.1002/pu.31522","doi":"10.1002/pu.31522","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-15 02:20:13","last_checked_at":"2026-11-16 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6071#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6070,"title":"Single dose of psilocybin shows extended benefit in depression trial","authors":"","journal":"The Brown University Psychopharmacology Update","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1002/pu.31528","pubmed_id":null,"openalex_id":"https://openalex.org/W7228923404","source_url":"https://doi.org/10.1002/pu.31528","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-11-15 02:20:13","last_checked":"2026-11-16 02:20:19","bibtex":null,"source_record_id":"DOI:10.1002/pu.31528","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1002/pu.31528","source_url":"https://doi.org/10.1002/pu.31528","doi":"10.1002/pu.31528","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-15 02:20:13","last_checked_at":"2026-11-16 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6070#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6069,"title":"How Does Psilocybin Affect Daily Life Experience and Behavior? Protocol For a Multimethod Ambulatory Assessment Study Within a Clinical Trial of Psilocybin for Depression","authors":"Sutu, A.; Kaplan, D.; Raison, C. L.; Sauder, C. J.; Arconada Alvarez, S. J.; Pozzo, N. S.; Salako, Z.; Chen, Z. J.; Palitsky, R.","journal":"medRxiv","publication_date":"2026-11-12","publication_year":2026,"doi":"10.64898/2026.11.10.26367628","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.11.10.26367628","substance_tags":"psilocybin","topic_tags":"Depression,Wellbeing,Clinical Trial,Review Article,Observational Study,Drug Interactions","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-11-13 02:22:01","last_checked":"2026-11-16 02:20:50","bibtex":null,"source_record_id":"DOI:10.64898/2026.11.10.26367628","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.11.10.26367628","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.11.10.26367628","source_url":"https://doi.org/10.64898/2026.11.10.26367628","doi":"10.64898/2026.11.10.26367628","pmid":"","publication_date":"2026-11-12","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-13 02:22:01","last_checked_at":"2026-11-16 02:20:50","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6069#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6068,"title":"From Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics.","authors":"Kim J, Fogaca MV, Munguba H, Pignatelli M, Platholi J, Woodburn SC, Ma 马振中 ZZ.","journal":"The Journal of neuroscience: the official journal of the Society for Neuroscience","publication_date":"2026-11-11","publication_year":2026,"doi":"10.1523/jneurosci.1198-26.2026","pubmed_id":"43015122","openalex_id":null,"source_url":"https://doi.org/10.1523/jneurosci.1198-26.2026","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-13 02:20:06","last_checked":"2026-11-16 02:20:15","bibtex":null,"source_record_id":"PMID:43015122","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1523/jneurosci.1198-26.2026","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:43015122","source_url":"https://doi.org/10.1523/jneurosci.1198-26.2026","doi":"10.1523/jneurosci.1198-26.2026","pmid":"43015122","publication_date":"2026-11-11","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-13 02:20:06","last_checked_at":"2026-11-16 02:20:15","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6068#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6067,"title":"Exploring subacute effects of a DMT and harmine meditation retreat on the brain's control energy landscape","authors":"Llano Aristizabal, I.; Hefter, K.; Kulkarni, S. S.; Egger, K.; Scheidegger, M.; Tamir, D. I.; Bassett, D. S.","journal":"bioRxiv","publication_date":"2026-11-11","publication_year":2026,"doi":"10.64898/2026.11.07.764538","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.11.07.764538","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Default Mode Network,Safety,Drug Interactions","study_type":"Clinical Trial","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-11-12 02:26:45","last_checked":"2026-11-16 02:24:58","bibtex":null,"source_record_id":"DOI:10.64898/2026.11.07.764538","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.11.07.764538","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.11.07.764538","source_url":"https://doi.org/10.64898/2026.11.07.764538","doi":"10.64898/2026.11.07.764538","pmid":"","publication_date":"2026-11-11","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-12 02:26:45","last_checked_at":"2026-11-16 02:24:58","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6067#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6066,"title":"A Placebo Cannot Be Psychedelic: Why psychedelic trials need dose, not mimicry, as their control","authors":"Wolfgang Liedtke","journal":"PsyArXiv","publication_date":"2026-11-10","publication_year":2026,"doi":"10.31234/osf.io/hkq53","pubmed_id":null,"openalex_id":null,"source_url":"https://osf.io/preprints/psyarxiv/hkq53_v1","substance_tags":"psilocybin","topic_tags":"Pharmacology,Clinical Trial,Animal Study","study_type":"Clinical Trial","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-11-11 02:25:52","last_checked":"2026-11-16 02:26:10","bibtex":null,"source_record_id":"DOI:10.31234/osf.io/hkq53","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://osf.io/preprints/psyarxiv/hkq53_v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/hkq53","source_url":"https://osf.io/preprints/psyarxiv/hkq53_v1","doi":"10.31234/osf.io/hkq53","pmid":"","publication_date":"2026-11-10","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-11 02:25:52","last_checked_at":"2026-11-16 02:26:10","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6066#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6065,"title":"Psychedelic-assisted therapies (Psilocybin and MDMA) for treatment-resistant psychiatric disorders","authors":"Gurgel Maria Luiza Góes, Ferreira Ana Luísa Carrijo, Mello Luisa da Costa, Caldato Amanda Comandolli, Canto Sofia Zaher do, Camilotti Pietra Brossi, Silva Manuela Ruela Folino, Gomes Raissa Assalin, Wiltemburg Beatriz Bomfim, Perini Giulia Spadone, Bertipaglia Manoela Rosa, Matos Rafaella Barcelos de, Orsi Enzo Seletti, Nacle Fernanda Oliveira, Ribeiro Gabriela Fernandes Daniel","journal":"International Health Sciences Review","publication_date":"2026-11-10","publication_year":2026,"doi":"10.70164/ihsr.v2i6.268","pubmed_id":null,"openalex_id":"https://openalex.org/W7225760100","source_url":"https://doi.org/10.70164/ihsr.v2i6.268","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-11-11 02:20:14","last_checked":"2026-11-16 02:20:19","bibtex":null,"source_record_id":"DOI:10.70164/ihsr.v2i6.268","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.70164/ihsr.v2i6.268","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.70164/ihsr.v2i6.268","source_url":"https://doi.org/10.70164/ihsr.v2i6.268","doi":"10.70164/ihsr.v2i6.268","pmid":"","publication_date":"2026-11-10","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-11 02:20:14","last_checked_at":"2026-11-16 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6065#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6064,"title":"Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients","authors":"Belinger Lydia, Moujaes Flora, von Rotz Robin, Rieser Nathalie M., Funk Xaver, Egger Klemens, Meinhold Lena, Renkert Maike, Stämpfli Philipp, Herdener Marcus, Vollenweider Franz X., Preller Katrin H.","journal":"Philosophical Transactions of the Royal Society B: Biological Sciences","publication_date":"2026-11-10","publication_year":2026,"doi":"10.1098/rstb.2025.0168","pubmed_id":"43007824","openalex_id":"https://openalex.org/W7225725324","source_url":"https://doi.org/10.1098/rstb.2025.0168","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-11-11 02:20:04","last_checked":"2026-11-16 02:20:19","bibtex":null,"source_record_id":"PMID:43007824","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1098/rstb.2025.0168","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:43007824","source_url":"https://doi.org/10.1098/rstb.2025.0168","doi":"10.1098/rstb.2025.0168","pmid":"43007824","publication_date":"2026-11-10","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-11 02:20:04","last_checked_at":"2026-11-16 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6064#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6063,"title":"The Bicuspid Aortic Valve Within the Therapeutic Window of Cannabis, Tryptamines, and Novel Neuroplastogen Analogs: A Mechanistic Risk Analysis Anchored to a Reconstructed openSNP Genotype Cohort","authors":"Henry P.","journal":"Preprints.org","publication_date":"2026-11-03","publication_year":2026,"doi":"10.20944/preprints202611.0177.v1","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.20944/preprints202611.0177.v1","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Observational Study,Safety,Drug Interactions,Genomics","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-11-10 02:20:14","last_checked":"2026-11-10 02:20:14","bibtex":null,"source_record_id":"DOI:10.20944/preprints202611.0177.v1","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.20944/preprints202611.0177.v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.20944/preprints202611.0177.v1","source_url":"https://doi.org/10.20944/preprints202611.0177.v1","doi":"10.20944/preprints202611.0177.v1","pmid":"","publication_date":"2026-11-03","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-10 02:20:14","last_checked_at":"2026-11-10 02:20:14","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6063#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6062,"title":"Psilocybin for anorexia nervosa: efficacy, safety, and durability of clinical effects: a systematic review of clinical trials","authors":"Eskandar Kirolos, Shahat Kerolos","journal":"Debates em Psiquiatria","publication_date":"2026-11-09","publication_year":2026,"doi":"10.25118/2763-9037.2026.v16.1677","pubmed_id":null,"openalex_id":"https://openalex.org/W7225655046","source_url":"https://doi.org/10.25118/2763-9037.2026.v16.1677","substance_tags":"psilocybin","topic_tags":"Anxiety,Eating Disorders,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-11-10 02:20:12","last_checked":"2026-11-16 02:20:14","bibtex":null,"source_record_id":"DOI:10.25118/2763-9037.2026.v16.1677","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.25118/2763-9037.2026.v16.1677","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.25118/2763-9037.2026.v16.1677","source_url":"https://doi.org/10.25118/2763-9037.2026.v16.1677","doi":"10.25118/2763-9037.2026.v16.1677","pmid":"","publication_date":"2026-11-09","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-10 02:20:12","last_checked_at":"2026-11-16 02:20:14","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6062#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6061,"title":"Current perspectives in the pharmacological treatment of gambling disorder: psychedelics and beyond.","authors":"Chiappini S, Maremmani AGI, Cavallotto C, Marrangone C, Amerio A, Lupi M, Pettorruso M, Martinotti G.","journal":"Expert opinion on pharmacotherapy","publication_date":"2026-11-13","publication_year":2026,"doi":"10.1080/14656566.2026.2761183","pubmed_id":"43002438","openalex_id":null,"source_url":"https://doi.org/10.1080/14656566.2026.2761183","substance_tags":"psilocybin","topic_tags":"Addiction,Neuroplasticity,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-10 02:20:04","last_checked":"2026-11-16 02:20:15","bibtex":null,"source_record_id":"PMID:43002438","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1080/14656566.2026.2761183","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:43002438","source_url":"https://doi.org/10.1080/14656566.2026.2761183","doi":"10.1080/14656566.2026.2761183","pmid":"43002438","publication_date":"2026-11-13","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-10 02:20:04","last_checked_at":"2026-11-16 02:20:15","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6061#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6060,"title":"Rapid antidepressant effects of psilocybin without increased SV2A binding: baseline binding predicts response","authors":"Yngwe, H.; Plaven Sigray, P.; Andersson, M.; Bolin, M.; Beckman, M.; Ekman, C.-J.; Tiger, M.; Lundberg, J.","journal":"medRxiv","publication_date":"2026-11-08","publication_year":2026,"doi":"10.64898/2026.11.06.26367247","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.11.06.26367247","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Animal Study","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-11-09 02:21:38","last_checked":"2026-11-15 02:21:36","bibtex":null,"source_record_id":"DOI:10.64898/2026.11.06.26367247","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.11.06.26367247","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.11.06.26367247","source_url":"https://doi.org/10.64898/2026.11.06.26367247","doi":"10.64898/2026.11.06.26367247","pmid":"","publication_date":"2026-11-08","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-09 02:21:38","last_checked_at":"2026-11-15 02:21:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6060#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6059,"title":"Psilocybin-assisted therapy for alcohol use disorder: A systematic review of randomized controlled trials","authors":"Eskandar Kirolos, Shahat Kerolos","journal":"Pharmacotherapy in Psychiatry and Neurology","publication_date":"2026-11-06","publication_year":2026,"doi":"10.17219/fpn/242405","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.17219/fpn/242405","substance_tags":"psilocybin","topic_tags":"Addiction,Randomized Controlled Trial,Systematic Review,Review Article","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-11-07 02:20:21","last_checked":"2026-11-13 02:20:15","bibtex":null,"source_record_id":"DOI:10.17219/fpn/242405","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.17219/fpn/242405","source_url":"https://doi.org/10.17219/fpn/242405","doi":"10.17219/fpn/242405","pmid":"","publication_date":"2026-11-06","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-07 02:20:21","last_checked_at":"2026-11-13 02:20:15","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6059#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6058,"title":"Pharmacist Guide to Psilocybin and Psychedelic-Assisted Psychotherapy.","authors":"Vandiver JW, Anderson BK, Suyama TL, French AR.","journal":"American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists","publication_date":"2026-11-06","publication_year":2026,"doi":"10.1093/ajhp/zxag388","pubmed_id":"42992418","openalex_id":"https://openalex.org/W7225427439","source_url":"https://doi.org/10.1093/ajhp/zxag388","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Drug Interactions,Contraindications","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-07 02:20:06","last_checked":"2026-11-13 02:20:16","bibtex":null,"source_record_id":"PMID:42992418","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1093/ajhp/zxag388","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42992418","source_url":"https://doi.org/10.1093/ajhp/zxag388","doi":"10.1093/ajhp/zxag388","pmid":"42992418","publication_date":"2026-11-06","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-07 02:20:06","last_checked_at":"2026-11-13 02:20:16","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6058#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6057,"title":"Psilocybin for Amblyopia - Targeting Critical Periods in Humans (PATCH)","authors":"Johns Hopkins University","journal":"ClinicalTrials.gov","publication_date":"2026-11-05","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07920081","substance_tags":"psilocybin","topic_tags":"Emotional Processing,Safety","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-11-06 02:24:24","last_checked":"2026-11-12 02:27:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07920081","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07920081","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07920081","source_url":"https://clinicaltrials.gov/study/NCT07920081","doi":"","pmid":"","publication_date":"2026-11-05","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-06 02:24:24","last_checked_at":"2026-11-12 02:27:42","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6057#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6056,"title":"A Topology of the Psilocybin Experience Reveals Cognitive-Emotional Drivers, Unitive State Divergence, and Psychometric Feature Cancellation","authors":"Amir Padovitz, Glenn Hartelius","journal":"PsyArXiv","publication_date":"2026-11-05","publication_year":2026,"doi":"10.31234/osf.io/be5qp","pubmed_id":null,"openalex_id":null,"source_url":"https://osf.io/preprints/psyarxiv/be5qp_v1","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Pharmacology,Mechanism of Action,Consciousness,Biomarkers,Aging,Emotional Processing","study_type":"Other","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-11-06 02:24:20","last_checked":"2026-11-12 02:27:38","bibtex":null,"source_record_id":"DOI:10.31234/osf.io/be5qp","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://osf.io/preprints/psyarxiv/be5qp_v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/be5qp","source_url":"https://osf.io/preprints/psyarxiv/be5qp_v1","doi":"10.31234/osf.io/be5qp","pmid":"","publication_date":"2026-11-05","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-06 02:24:20","last_checked_at":"2026-11-12 02:27:38","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6056#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6055,"title":"Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?","authors":"Davies Todd, Coustasse Alberto","journal":"The Permanente Journal","publication_date":"2026-11-05","publication_year":2026,"doi":"10.7812/tpp/26.139","pubmed_id":null,"openalex_id":"https://openalex.org/W7225290245","source_url":"https://doi.org/10.7812/tpp/26.139","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-11-06 02:20:26","last_checked":"2026-11-12 02:20:19","bibtex":null,"source_record_id":"DOI:10.7812/tpp/26.139","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.7812/tpp/26.139","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.7812/tpp/26.139","source_url":"https://doi.org/10.7812/tpp/26.139","doi":"10.7812/tpp/26.139","pmid":"","publication_date":"2026-11-05","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-06 02:20:26","last_checked_at":"2026-11-12 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6055#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6054,"title":"Psilocybin as a novel drug in the treatment of major depressive disorder: a systematic review","authors":"Magdziak Jakub, Borowska Oliwia, Mędrek Eliza, Zegarska Paulina, Sałkowska Natalia, Brzozowska Natalia, Zawadzka Karolina, Wardzyńska Barbara, Awad Sara, Markowska Hanna, Małyszczak Paulina, Zięba Katarzyna","journal":"Medical Science","publication_date":"2026-10-30","publication_year":2026,"doi":"10.54905/disssi.v30i176.e201ms3896","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.54905/disssi.v30i176.e201ms3896","substance_tags":"psilocybin","topic_tags":"Depression,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-11-06 02:20:26","last_checked":"2026-11-06 02:20:26","bibtex":null,"source_record_id":"DOI:10.54905/disssi.v30i176.e201ms3896","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.54905/disssi.v30i176.e201ms3896","source_url":"https://doi.org/10.54905/disssi.v30i176.e201ms3896","doi":"10.54905/disssi.v30i176.e201ms3896","pmid":"","publication_date":"2026-10-30","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-06 02:20:26","last_checked_at":"2026-11-06 02:20:26","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6054#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6053,"title":"Psilocybin modulates nucleus accumbens activity via astrocytic transcriptional regulation.","authors":"Kang SM, Kang DS, Choi TY, Jeong S, Lee AH, Jeong Y, Oh M, Kim EJ, Lee J, Kim KJ, Lee CJ, Lim NY, Na TW, Lee BH, Bae JS, Park SJ, Chang S, Koo JW.","journal":"Experimental & molecular medicine","publication_date":"2026-11-05","publication_year":2026,"doi":"10.1038/s12276-026-01872-3","pubmed_id":"42988866","openalex_id":"https://openalex.org/W7225292428","source_url":"https://doi.org/10.1038/s12276-026-01872-3","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Mechanism of Action,Receptor Pharmacology","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-06 02:20:26","last_checked":"2026-11-12 02:20:19","bibtex":null,"source_record_id":"PMID:42988866","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s12276-026-01872-3","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42988866","source_url":"https://doi.org/10.1038/s12276-026-01872-3","doi":"10.1038/s12276-026-01872-3","pmid":"42988866","publication_date":"2026-11-05","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-06 02:20:26","last_checked_at":"2026-11-12 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6053#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}}],"total":5167,"page":1,"per_page":20,"pages":259,"resource":"papers","filters":{"notification":null,"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}